| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.1B | $2.0B | $1.7B | $1.4B | $1.4B | $1.4B | $1.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.6B | $0.6B | $0.6B | $0.4B | $0.3B | $0.4B | $0.5B |
| EPS (Basic) | $9.92 | $8.88 | $9.11 | $8.84 | $6.79 | $5.11 | $6.89 | $6.97 |
| EPS (Diluted) | $9.92 | $8.87 | $9.10 | $8.81 | $6.76 | $5.10 | $6.84 | $6.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $53.0B | $52.5B | $50.8B | $52.9B | $50.9B | $42.4B | $34.0B | $32.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $48.5B | $48.6B | $47.1B | $49.8B | $46.4B | $38.1B | $30.1B | $28.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.6B | $3.9B | $3.7B | $3.1B | $4.4B | $4.3B | $3.9B | $3.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $1.0B | $0.5B | $0.7B | $0.6B | $0.5B | $0.6B | — |
| Investing Cash Flow | $-1.6B | $-0.2B | $-0.9B | $-8.3B | $-2.5B | $-1.6B | $-1.4B | — |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.0B | $0.7B | $-2.9B | $3.0B | $8.2B | $7.6B | $0.6B | — |